RRC Northridge is a medicare approved dialysis facility center in Northport, Alabama and it has 24 dialysis stations. It is located in Tuscaloosa county at 4400 Watermelon Road, Northport, AL, 35473. You can reach out to the office of RRC Northridge at (205) 722-2968. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. RRC Northridge has the following ownership type - Profit. It was first certified by medicare in October, 2006. The medicare id for this facility is 012618 and it accepts patients under medicare ESRD program.
| Name | RRC Northridge |
|---|---|
| Location | 4400 Watermelon Road, Northport, Alabama |
| No. of Dialysis Stations | 24 |
| Medicare ID | 012618 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 4400 Watermelon Road, Northport, Alabama, 35473 | |
| (205) 722-2968 | |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| NPI Number | 1144459769 |
| Organization Name | Rrc Northridge |
| Doing Business As | Reliant Renal Care-alabama, Llc |
| Address | 4400 Watermelon Rd # A Northport, Alabama, 35473 |
| Phone Number | (205) 722-2968 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| NPI Number | 1538311196 |
| Doing Business As | Northridge Dialysis Center, Llc |
| Address | 4400 Watermelon Road Northport, Alabama, 35473 |
| Phone Number | (239) 594-8758 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 56% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 14% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 30% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 54% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 14% |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 51% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 16% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 33% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 53% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 12% |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 74% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 26% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 62% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 25% | 12% |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 61 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 23 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 75 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 670 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 42 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 346 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 90 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at RRC Northridge with elevated calcium levels.
| Patients with hypercalcemia | 117 |
| Hypercalcemia patient months | 1048 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 127 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 24 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 28 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 76 |
| Patient months included in arterial venous fistula and catheter summaries | 514 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 38 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 18 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 104 |
| Hospitalization Rate in facility | 154.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 267.4 |
| Hospitalization Rate: Lower Confidence Limit | 97.2 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at RRC Northridge were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 23.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 32.4 |
| Readmission Rate: Lower Confidence Limit | 15.8 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at RRC Northridge get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .4 (As Expected) |
| SIR: Upper Confidence Limit | 1.3 |
| SIR: Lower Confidence Limit | .07 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether RRC Northridge's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 95 |
| Transfusion Rate in facility | 29.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 68.3 |
| Transfusion Rate: Lower Confidence Limit | 14.3 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at RRC Northridge lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 462 |
| Mortality Rate in facility | 19.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.4 |
| Mortality Rate: Lower Confidence Limit | 15.1 |
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago
News Archive
TIAA-CREF, America's largest private retirement system, today announced a relationship with the National Forum for Latino Healthcare Executives, a national nonprofit organization led by senior executive healthcare leaders in the U.S. that works with the healthcare system to meet the needs of diverse communities throughout the nation.
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.
The Wall Street Journal: "More employers are scrutinizing employees' health-insurance dependents in order to weed out ineligible beneficiaries" in an effort to cut costs. "Benefits-consulting companies say interest in dependent audits has been growing for the past few years, but has ticked up more recently. … These companies aim to verify the relationships of dependents such as spouses and children, soliciting documents including marriage and birth certificates. In many cases, employers haven't previously asked employees to verify dependents' eligibility" (Mattioli, 11/22).
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
› Verified 6 days ago